Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance R. R. GriffithsW. A. RichardsR. Jesse Original Investigation 07 July 2006 Pages: 268 - 283
Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. David E. Nichols Commentary 07 July 2006 Pages: 284 - 286
Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. Solomon H. Snyder Commentary 07 July 2006 Pages: 287 - 288
Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. Charles R. Schuster Commentary 07 July 2006 Pages: 289 - 290
Commentary on: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance by Griffiths et al. Herbert D. Kleber Commentary 07 July 2006 Pages: 291 - 292
Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine K. ItoT. AbekawaT. Koyama Original Investigation 01 June 2006 Pages: 293 - 302
Chronic lithium chloride administration to rats elevates glucose metabolism in wide areas of brain, while potentiating negative effects on metabolism of dopamine D2-like receptor stimulation Mireille BasselinLisa ChangStanley I. Rapoport Original Investigation 20 June 2006 Pages: 303 - 311
The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine Robert S. KernMichael F. GreenRon Marcus Original Investigation 30 June 2006 Pages: 312 - 320
Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes Angela N. DukeDonna M. PlattJames K. Rowlett Original Investigation 17 June 2006 Pages: 321 - 330
Paradoxical effects of prenatal acetylcholinesterase blockade on neuro-behavioral development and drug-induced stereotypies in reeler mutant mice Giovanni LaviolaWalter AdrianiFlavio Keller Original Investigation 17 June 2006 Pages: 331 - 344
Atypical anxiolytic-like response to naloxone in benzodiazepine-resistant 129S2/SvHsd mice: role of opioid receptor subtypes R. J. RodgersR. AugarA. J. Tallett Original Investigation 27 June 2006 Pages: 345 - 355
The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements Philip D. HarveyMichael F. GreenAntony Loebel Original Investigation 17 June 2006 Pages: 356 - 363
Venlafaxine compromises the antinociceptive actions of gabapentin in rat models of neuropathic and persistent pain Frederik RodeTine BroløsOle J. Bjerrum Original Investigation 17 June 2006 Pages: 364 - 375
A role for corticotropin-releasing factor, but not corticosterone, in acute food-deprivation-induced reinstatement of heroin seeking in rats Uri ShalevPeter S. FinniePriti Wahi Original Investigation 01 June 2006 Pages: 376 - 384
The early time course of smoking withdrawal effects Peter S. HendricksJoseph W. DitreThomas H. Brandon Original Investigation 03 June 2006 Pages: 385 - 396
